Deep­en­ing US foot­print, As­traZeneca-part­nered French biotech In­nate shoots for $100M IPO

6 years ago
Financing

Akcea’s top 3 C-suite ex­ecs are chopped out as Io­n­is sends in an in­ter­im quar­ter­back from their bench

6 years ago
R&D

Amid Wood­ford de­ba­cle, Im­muno­core cuts val­u­a­tion as it se­cures $74M from Gen­er­al At­lantic — re­port

6 years ago
Financing

New Flag­ship biotech wants to un­leash your genome

6 years ago
Startups

A long-suf­fer­ing Clo­vis makes a leap in­to ra­dio­phar­ma­ceu­ti­cals, pay­ing $12M in cash to beef up the pipeline

6 years ago
Deals

Here comes the oral GLP-1 drug for di­a­betes — and No­vo Nordisk wants to price Ry­bel­sus 'at a sim­i­lar lev­el as ...

6 years ago
R&D
Pharma

Astel­las/Fi­bro­Gen's ane­mia drug for CKD pa­tients ap­proved in Japan; Re­searchers pro­pose com­bo to stay ahead of KRAS ...

6 years ago
News Briefing

Astel­las' AML drug wins over CHMP — strength­en­ing lead on Dai­ichi Sankyo

6 years ago
Pharma

In­trex­on unit push­es back against claims its GM mos­qui­toes are mak­ing dis­ease-friend­ly mu­tants

6 years ago
R&D
FDA+

Chris Roberts jumps back in­to biotech with CSO gig at Black Di­a­mond; Trou­bled Five Prime ap­points in­ter­im CEO

6 years ago
Peer Review

Pur­due threat­ens to walk away from set­tle­ment, asks to pay em­ploy­ees mil­lions in bonus­es

6 years ago
Pharma

Boehringer In­gel­heim en­lists an­oth­er vir­tu­al biotech part­ner for its for­ay in­to reti­nal dis­eases

6 years ago
Deals

Genen­tech sub­mits a big plan to ex­pand its South San Fran­cis­co foot­print

6 years ago
R&D
Pharma

As Nas­daq en­rolls the fi­nal batch of 2019 IPOs, how have the num­bers com­pared to past years?

6 years ago
Financing

Em­maus re­scinds EU mar­ket­ing ap­pli­ca­tion, fol­low­ing neg­a­tive re­view

6 years ago
Pharma
FDA+

While No­var­tis ban­ish­es Zol­gens­ma scan­dal scars — Bio­gen goes on a Spin­raza 'of­fen­sive'

6 years ago
R&D
Pharma

Eye­ing big ther­a­peu­tic push, Gink­go bags $290M to build a cell pro­gram­ming em­pire

6 years ago
Financing

Speak­er Nan­cy Pelosi to un­veil bill for fed­er­al­ly ne­go­ti­at­ed drug prices

6 years ago
People
Pharma

Alzheimer’s re­search in line for $350M boost as Sen­ate pro­pos­es $3B hike to NIH bud­get; Al­lo­gene teams up with ...

6 years ago
News Briefing

Can­cer tri­als aimed at 'sur­ro­gate' tar­gets miss big­ger mark — study

6 years ago
R&D

Zol­gens­ma did­n't cause an in­fant death, AveX­is ex­ecs say as they spot­light long-term da­ta

6 years ago
R&D
Pharma

Jeff Kindler's Cen­trex­ion re­news bid to make pub­lic de­but

6 years ago
Financing
Startups

'A fourth rev­o­lu­tion in can­cer ther­a­pies': ARCH-backed Bound­less Bio flash­es big check, makes big­ger promis­es in ...

6 years ago
Financing
Startups

Biotech boards bur­dened: Bridg­ing the suc­cess gap

6 years ago
Financing
Startups
First page Previous page 897898899900901902903 Next page Last page
A service from the Financial Times